The effect of growth hormone on rat myocardial collagen

Growth Hormone and IGF Research

Volumn 9, Issue 2, 1999, Pages 123-130

  Brüel, Annemarie ^a   Oxlund, Hans ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Collagen; Collagen types; Cross links; Growth hormone; Myocardium; Rat

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; HUMAN GROWTH HORMONE; PYRIDINOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; FEMALE; HEART MUSCLE; HEART VENTRICLE; HEART WEIGHT; MORPHOMETRICS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033137116     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.1999.0097     Document Type: Article

References (48)

1. Thuesen L, Christiansen JS, Sørensen KE, Jørgensen JOL, Ørskov H, Henningsen P. Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan Med Bull 1988; 35: 193-196.
2. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Saccá L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996; 334: 809-814.
3. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hänlein D, Willenbrock R, Anker SD, Poole-Wilson P A, Ranke M B, Dietz R. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998; 351: 1233-1237.
4. Penny DG, Dunbar JC, Baylerian MS. Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour. Cardiovasc Res 1985; 19: 270-277.
5. Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and insulin- like growth factor-1 in the rat - A combined in vivo and in vitro evaluation. Circulation 1996; 93: 800-809.
6. 2+ handling and enhance cardiac performance - In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. Circ Res 1996; 79: 227-236.
7. Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato N S, Weisberg A S, Lubetzski J, Lecarpentier Y, Winegrad S, Mercadier J J. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 1990; 86: 507-515.
8. Mayoux E, Ventura-Clapier R, Timsit J, Behar-Cohen F, Hoffmann C, Mercadier JJ. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res 1993; 72: 57-64.
9. Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross J Jr. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 1996; 93: 2188-2196.
10. Isgaard J, Kujacic V, Jennische E, Holmäng A, Sun X Y, Hedner T, Hjalmarson Å, Bengtsson B-Å. Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest 1997; 27: 517-525.
11. Brüel A, Oxlund H. Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart. Eur J Endocrinol 1995; 132: 195-199.
12. Brüel A, Oxlund H. Biosynthetic growth hormone changes the collagen and elastin contents and the biomechanical properties of the rat aorta. Acta Endocrinol 1991; 125: 49-57.
13. Ørtoft G, Kelly C, Brüel A, Smith A, Carter N, Oxlund H. Glucocorticoids inhibit the growth hormone induced increase in serum IGF-I and its mRNA, body weight and muscle mass of rats. Eur J Exp Musculoskel Res 1993; 2: 135-142.
14. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967; 18: 267-273.
15. Neuman RE, Logan MA. The determination of collagen and elastin in tissues. J Biol Chem 1950; 186: 549-556.
16. Laurent GJ, Cockerill P, McAnulty RJ, Hastings JRB. A simplified method for quantitation of the relative amounts of type I and type III collagen in small tissue samples. Anal Biochem 1981; 113: 301-312.
17. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 169: 197-203.
18. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal Biochem 1984; 137: 380-388.
19. Puchtler H, Waldrop FS, Valentine LS. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr Pathol 1973; 150: 174-187.
20. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990; 212: 424-431.
21. Kopple JD. The rationale for the use of growth hormone or insulin-like growth factor I in adult patients with renal failure. Miner Electrolyte Metab 1992; 18: 269-275.
22. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991; 99: 1495-1500.
23. Timsit J, Mercadier JJ. Effects of chronic growth hormone excess on cardiac contractility and myosin phenotype in the rat. Acta Paediatr Suppl 1992; 383: 32-34.
24. Prysor-Jones RA, Jenkins JS. Effect of excessive secretion of growth hormone on tissues of the rat, with particular reference to the heart and skeketal muscle. J Endocrinol 1980; 85: 75-82.
25. Rubin SA, Buttrick P, Malhotra A, Melmed S, Fishbein MC. Cardiac physiology, biochemistry and morphology in response to excess growth hormone in the rat. J Mol Cell Cardiol 1990; 22: 429-438.
26. Lei LQ, Rubin SA, Fishbein MC. Cardiac architectural changes with hypertrophy induced by excess growth hormone in rats. Lab Invest 1988; 59: 357-362.
27. Iimoto DS, Covell JW, Harper E. Increase in cross-linking of type I and type III collagens associated with volume-overload hypertrophy. Circ Res 1988; 63: 399-408.
28. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988; 62: 757-765.
29. Speiser B, Riess CF, Schaper J. The extracellular matrix in human myocardium: Part I: Collagens I, III, IV, and VI. Cardioscience 1991; 2: 225-232.
30. Caulfield JB, Borg TK. The collagen network of the heart. Lab Invest 1979; 40: 364-372.
31. MacKenna DA, Omens JH, Covell JW. Left ventricular perimysial collagen fibers uncoil rather than stretch during diastolic filling. Basic Res Cardiol 1996; 91: 111-122.
32. Michel JB, Salzmann JL, Nlom MO, Bruneval P, Barres D, Camilleri JP. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 1986; 81: 142-154.
33. Medugorac I. Myocardial collagen in different forms of heart hypertrophy in the rat. Res Exp Med 1980; 177: 201-211.
34. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989; 64: 1041-1050.
35. Doering CW, Jalil JE, Janicki JS, Pick R, Aghili S, Abrahams C, Weber K T. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988; 22: 686-695.
36. Kato S, Spinale FG, Tanaka R, Johnson W, Cooper G, Zile MR. Inhibition of collagen cross-linking: Effects on fibrillar collagen and ventricular diastolic function. Am J Physiol 1995; 269: H863-H868.
37. Gilbert PL, Siegel RJ, Melmed S, Sherman CT, Fishbein MC. Cardiac morphology in rats with growth hormone-producing tumours. J Mol Cell Cardiol 1985; 17: 805-811.
38. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardi G, Saccá L. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994; 79: 441-446.
39. Cuocolo A, Nicolai E, Fazio S, Pace L, Maurea S, Cittadini A, Saccá L, Salvatore M. Impaired left ventricular diastolic filling in patients with acromegaly: Assessment with radionuclide angiography. J Nucl Med 1995; 36: 196-201.
40. Lie JT, Grossman SI. Pathology of the heart in acromegaly, anatomic findings in 27 autopsied patients. Am Heart J 1980; 100: 41-52.
41. Hejtmancik MR, Bradfield JY, Herrmann GR. Acromegaly and the heart: A clinical and pathologic study. Ann Int Med 1951; 34: 1445-1456.
42. Nabarro JDN. Acromegaly. Clin Endocrinol 1987; 26: 481-512.
43. Fazio S, Colao A, Sabatini D, Merola B, Riccio G, Ferone D, Biondi B, Lombardi G, Saccá L. Effects of short-term acromegaly on cardiac morphology and function. 10th International Congress of Endocrinology 1996; p.472, P2-272 (Abstract)
44. Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994; 15: 555-573.
45. Jørgensen KD. Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats. Acta Endocrinol 1987; 114: 124-131.
46. Jørgensen KD, Svendsen O, Greenough RJ, Kallesen T, Goburdhun R, Skydsgaard K, Finch J, Dinesen B, Nilsson P. Biosynthetic human growth hormone: Subchronic toxicity studies in rats and monkeys. Pharmacol Toxicol 1988; 62: 329-333.
47. Clark RG, Carlsson LMS, Robinson ICAF. Growth hormone secretory profiles in conscious female rats. J Endocrinol 1987; 114: 399-407.
48. Jørgensen PH, Bang C, Andreassen TT, Flyvbjerg A, Orskov H. Dose-response study of the effect of growth hormone on mechanical properties of skin graft wounds. J Surg Res 1995; 58: 295-301.